These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2790331)

  • 1. Autoantibody analysis in chronic graft-versus-host disease.
    Holmes JA; Livesey SJ; Bedwell AE; Amos N; Whittaker JA
    Bone Marrow Transplant; 1989 Sep; 4(5):529-31. PubMed ID: 2790331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren-like syndrome after bone marrow transplantation.
    Kosrirukvongs P; Chirapapaisan N; Visuthisakchai S; Issaragrisil S; Gonggetyai V
    J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
    Siegert W; Stemerowicz R; Hopf U
    Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of chronic graft-versus-host disease after unrelated-donor bone marrow transplantation. Kanazawa University Bone Marrow Transplant Team].
    Takami A; Nakao S; Ueda M; Takamatsu H; Sugimori N; Yamazaki H; Miura H; Ito K; Yamaguchi M; Niki T
    Rinsho Ketsueki; 1995 Jan; 36(1):6-11. PubMed ID: 7715080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
    Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
    Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
    Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
    Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
    Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graft-versus-host disease as the cause of symptoms mimicking Sjögren's syndrome].
    Tuchocka-Piotrowska A; Puszczewicz M; Kołczewska A; Majewski D
    Ann Acad Med Stetin; 2006; 52 Suppl 2():89-93. PubMed ID: 17474179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
    Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.